Exactech Announces FDA Breakthrough Device Designation for JointMedica's Polymotion® Hip Resurfacing System
Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Device Designation for JointMedica’s Polymotion® Hip Resurfacing System. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220517005313/en/ Exactech Announces FDA Breakthrough Device Designation for
Source: channelbiz.co.uk